Insight - Beijing buyers club? China's cancer patients gamble on grey market

SHANGHAI (Reuters) - When her father's lung cancer worsened, Yin Min, a 51-year-old financial broker from Shanghai, faced a choice: pay nearly $3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China.

from Reuters: Top News http://uk.reuters.com/article/uk-china-cancer-black-market-insight-idUKKBN14E0J5?feedType=RSS&feedName=topNews